BMS 300 mg 3622 (Reyataz 300 mg)
Generic Name: atazanavir
Pill with imprint BMS 300 mg 3622 is Red / Blue, Capsule-shape and has been identified as Reyataz 300 mg. It is supplied by Bristol-Myers Squibb.
Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 300 mg 3622
Reyataz
- Generic Name:
- atazanavir
- Imprint:
- BMS 300 mg 3622
- Strength:
- 300 mg
- Color:
- Red / Blue
- Size:
- 23.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- Inactive Ingredients:
- crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 54569-5864 | A-S Medication Solutions, LLC (repackager) |
| 54868-5838 | Physicians Total Care Inc. (repackager) |
| 35356-0114 | Lake Erie Medical and Surgical Supply (repackager) |
More about Reyataz (atazanavir)
- Reyataz Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Generic Availability
- Drug class: protease inhibitors
- FDA Alerts (3)
Consumer resources
- Reyataz
- Reyataz (Atazanavir Capsules)
- Reyataz (Atazanavir Powder for Oral Suspension)
- Reyataz (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
